Optimum overall times II: Extended modelling for head and neck radiotherapy.

[1]  Michael C. Joiner,et al.  Basic Clinical Radiobiology , 2009 .

[2]  N. Slevin,et al.  Radiobiological modelling of UK head and neck schedules--calculation errors. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[3]  J F Fowler,et al.  Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[4]  J. Fenwick.  Delay differential equations and the dose-time dependence of early radiotherapy reactions. , 2006, Medical physics.

[5]  Srinivasan Vijayakumar,et al.  Technical Basis of Radiation Therapy , 2006 .

[6]  J. Fowler,et al.  Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Cai Grau,et al.  Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial , 2003, The Lancet.

[8]  Bengt Brorsson,et al.  The Swedish Council on Technology Assessment in Health Care (SBU) Systematic Overview of Radiotherapy for Cancer including a Prospective Survey of Radiotherapy Practice in Sweden 2001--Summary and Conclusions , 2003, Acta oncologica.

[9]  W. Dörr,et al.  Radiation-induced changes in cellularity and proliferation in human oral mucosa. , 2002, International journal of radiation oncology, biology, physics.

[10]  J. Fowler,et al.  Comments on `Standard effective doses for proliferative tumours' , 2000, Physics in medicine and biology.

[11]  J. Fowler,et al.  Confirmation of improved local-regional control with altered fractionation in head and neck cancer. , 2000, International journal of radiation oncology, biology, physics.

[12]  R. Dale,et al.  Biological equivalent dose assessment of the consequences of hypofractionated radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[13]  J H Hendry,et al.  Time factors in larynx tumor radiotherapy: lag times and intertumor heterogeneity in clinical datasets from four centers. , 1999, International journal of radiation oncology, biology, physics.

[14]  R. Dale,et al.  Mathematical models of tumour and normal tissue response. , 1999, Acta oncologica.

[15]  H. Thames,et al.  Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. , 1997, International journal of radiation oncology, biology, physics.

[16]  R. Dale,et al.  Derivation of the optimum dose per fraction from the linear quadratic model. , 1995, The British journal of radiology.

[17]  D. Shrieve,et al.  Optimal fractionation schedules in small field radiotherapy. , 1994, International journal of radiation oncology, biology, physics.

[18]  D. Brenner.  Accelerated repopulation during radiotherapy: Quantitative evidence for delayed onset , 1993 .

[19]  J. Fowler.  The linear-quadratic formula and progress in fractionated radiotherapy. , 1989, The British journal of radiology.

[20]  P. F. Gross,et al.  The Swedish Council on Technology Assessment in Health Care , 1989, International Journal of Technology Assessment in Health Care.

[21]  J. M. Taylor,et al.  The hazard of accelerated tumor clonogen repopulation during radiotherapy. , 1988, Acta oncologica.

[22]  E. Hall,et al.  Radiobiology for the radiologist , 1973 .